Similar articles

• [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].

  Lombardo M, Fusco M, Valente D. Lombardo M, et al. G Ital Cardiol. 1979;9(12):1363-70. G Ital Cardiol. 1979. PMID: 45015 Italian.
• [The potential of beta-blockaders in the management of hypertension].

  Bühler FR, Kowski W, Bolli P, Bertel O. Bühler FR, et al. Internist (Berl). 1978 Sep;19(9):510-9. Internist (Berl). 1978. PMID: 29849 German. No abstract available.
• Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.

  van Brummelen P, Bühler FR, Kiowski W, Bolli P, Bertel O. van Brummelen P, et al. Int J Clin Pharmacol Biopharm. 1979 Oct;17(10):380-5. Int J Clin Pharmacol Biopharm. 1979. PMID: 40887 Clinical Trial. No abstract available.
• [Beta blockaders in the treatment of hypertension. Part 2. Antihypertensive effect: hypotheses on the mechanism of action and practical methods of treatment].

  Andrejak M, Fournier A, Hardin JM, Lambrey G, de Frémont JF, Coevoet B. Andrejak M, et al. Coeur Med Interne. 1978 Jul-Sep;17(3):381-400. Coeur Med Interne. 1978. PMID: 31260 Review. French. No abstract available.
• [Current treatment of arterial hypertension and its complications].

  Teodorescu P, Câmpeanu A. Teodorescu P, et al. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1976 May-Jun;28(3):161-9. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1976. PMID: 7821 Review. Romanian. No abstract available.